South Africa Could Reduce HIV-Associated Long-Term Costs, Extend Lives With Earlier Treatment, Study Says

If South Africa followed WHO recommendations for earlier therapy for people living with HIV, thousands of lives could be extended and the country would start saving money after 16 years, according to a study recently published online in PLoS One, United Press International reports.

The study, which “used a mathematical model to predict the impact of adopting the new WHO guidelines on HIV prevalence, incidence and cost,” found the initial costs would “be greater because of the increased number of people now eligible for treatment,” the news agency writes, noting that in the long term, costs would decline because of a reduced number of HIV cases (7/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.